Figure 3From: Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial Average percent change in patient-reported symptoms between Days 0 and 36. RP-G28 (n = 42). Placebo (n = 20). p = 0.7291Back to article page